BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34564895)

  • 21. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of clinical remission using the C-peptide level in type 1 diabetes in children.
    Zmysłowska A; Młynarski W; Szadkowska A; Bodalski J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):71-4. PubMed ID: 17880810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
    Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
    Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis.
    Schwandt A; Kuss O; Dunstheimer D; Karges B; Kapellen T; Meissner T; Witsch M; Flury M; Straubinger S; Holl RW;
    J Pediatr; 2020 Mar; 218():64-71.e3. PubMed ID: 31952845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor.
    Bowden SA; Duck MM; Hoffman RP
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):197-201. PubMed ID: 18547233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle-to-fat ratio in children and adolescents with type 1 diabetes in predicting glycaemic control and partial clinical remission.
    Averbuch S; Yackobovitch-Gavan M; Ben Simon A; Interator H; Lopez A; Borger O; Laurian I; Dorfman A; Chorna E; Oren A; Eyal O; Brener A; Lebenthal Y
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3767. PubMed ID: 38407547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study.
    Lundgren M; Jonsdottir B; Elding Larsson H;
    Diabetologia; 2019 Jan; 62(1):53-57. PubMed ID: 30109365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.
    Nielens N; Pollé O; Robert A; Lysy PA
    J Diabetes Res; 2018; 2018():5936360. PubMed ID: 29568778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
    Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
    Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Theory of Hyperlipidemic Memory of Type 1 Diabetes.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():819544. PubMed ID: 35432186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.
    Redondo MJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Wood JR; Buckingham B; Klingensmith GJ; Silverstein J; Tamborlane WV;
    Pediatr Diabetes; 2014 Jun; 15(4):294-302. PubMed ID: 23889707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.
    Mazarello Paes V; Barrett JK; Dunger DB; Gevers EF; Taylor-Robinson DC; Viner RM; Stephenson TJ
    Pediatr Diabetes; 2020 Mar; 21(2):288-299. PubMed ID: 31782879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes.
    Chen Y; Xia Y; Xie Z; Zhong T; Tang R; Li X; Zhou Z
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e293-e302. PubMed ID: 34390338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The factors relevant to partial remission in children with type 1 diabetes mellitus after measles vaccination: A retrospective study.
    Bektaş G; Önal H; Adal E
    J Med Virol; 2020 Dec; 92(12):2955-2960. PubMed ID: 32108356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes.
    Niedzwiecki P; Pilacinski S; Uruska A; Adamska A; Naskret D; Zozulinska-Ziolkiewicz D
    J Diabetes Complications; 2015; 29(8):1105-11. PubMed ID: 26427560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.
    Moya R; Robertson HK; Payne D; Narsale A; Koziol J; ; Davies JD
    Clin Immunol; 2016 May; 166-167():72-80. PubMed ID: 27114212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.